| Date | Title | Description |
| 13.04.2025 | Circio Holding ASA: A New Dawn in RNA Technology | In the world of biotechnology, innovation is the lifeblood. Circio Holding ASA stands at the forefront, pushing the boundaries of what’s possible with RNA technology. The company recently published its Annual Report for 2024, revealing a la... |
| 11.04.2025 | Circio Holding ASA: Annual Report 2024 | Circio Holding ASA: Annual Report 2024
Fri, Apr 11, 2025 18:54 CET Report this content
Oslo, Norway, 11 April 2025 – Reference is made to the press release published on 10 April 2025, regarding the Board of Directors of Circio Holding ASA h... |
| 11.04.2025 | Circio Holding ASA: Annual Report 2024 - Correction to ESEF-file name | Circio Holding ASA: Annual Report 2024 - Correction to ESEF-file name
Fri, Apr 11, 2025 20:00 CET Report this content
Oslo, Norway, 11 April 2025 – Reference is made to the Annual Report, including European Single Electronic Format (ESEF), ... |
| 03.06.2024 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Mon, Jun 03, 2024 09:13 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 30.05.2024 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Thu, May 30, 2024 15:52 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 25.04.2024 | Circio Holding ASA: Annual Report 2023 | Circio Holding ASA: Annual Report 2023
Thu, Apr 25, 2024 23:49 CET Report this content
Oslo, Norway 25 April 2024 – the Board of Directors of Circio Holding ASA today approved the Company’s Annual Report, including the financial statements ... |
| 25.04.2024 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Thu, Apr 25, 2024 13:55 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 17.04.2024 | Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment | Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment
Wed, Apr 17, 2024 07:50 CET Report this content
Oslo, Norway 17 April 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology company develo... |
| 17.04.2024 | Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025 | Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025
Wed, Apr 17, 2024 07:55 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECT... |
| 17.04.2024 | Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus | Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus
Wed, Apr 17, 2024 08:00 CET Report this content
circVec results demonstrate significantly enhanced protein expressi... |
| 09.04.2024 | Circio invites to a company update on Wednesday 17 April 2024 | Circio invites to a company update on Wednesday 17 April 2024
Tue, Apr 09, 2024 07:00 CET Report this content
Oslo, Norway, 9 April 2024 – Circio Holding ASA (OSE: CRNA): Circio’s management invites to a company update hosted by Redeye on W... |
| 27.03.2024 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Wed, Mar 27, 2024 11:08 CET Report this content
Oslo, 27 March 2024: Reference is made to the stock exchange announcement by Circio Holding... |
| 21.03.2024 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Thu, Mar 21, 2024 12:44 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 19.03.2024 | Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China | Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China
Tue, Mar 19, 2024 12:43 CET Report this content The option exercise grants IOVaxis an exclusive ... |
| 13.03.2024 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Wed, Mar 13, 2024 09:41 CET Report this content
Oslo, 13 March 2024: Reference is made to the stock exchange announcement by Circio Holding... |
| 09.03.2024 | Circio Holding ASA: Bond Conversion Buzz | Circio Holding ASA experiences a buzz with requested conversion of convertible bonds. The Company's share capital sees an increase as Atlas Special Opportunities, LLC converts bonds into new shares. CEO Erik Digman Wiklund and Investor Rela... |
| 08.03.2024 | Circio Holding ASA: Approval and publication of prospectus | Circio Holding ASA: Approval and publication of prospectus
Fri, Mar 08, 2024 13:52 CET Report this content
Oslo, Norway, 8 March 2024: Reference is made to the stock exchange announcement published by Circio Holding ASA (the "Company&q... |
| 05.03.2024 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Tue, Mar 05, 2024 08:27 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 04.03.2024 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Mon, Mar 04, 2024 12:51 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 04.03.2024 | The TG01 IND application by Circio’s partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities | The TG01 IND application by Circio’s partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities
Mon, Mar 04, 2024 16:31 CET Report this content The IND application filed by partner IOVaxis Therapeutics to initiate ... |
| 27.02.2024 | Circio to participate in the Annual European Life Sciences CEO Forum in Zürich | Circio to participate in the Annual European Life Sciences CEO Forum in Zürich
Tue, Feb 27, 2024 07:00 CET Report this content
Oslo, Norway, 27 February 2024 – Circio Holding ASA (OSE: CRNA) announces that CFO Lubor Gaal is invited as a pan... |
| 07.02.2024 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Wed, Feb 07, 2024 11:07 CET Report this content
Oslo, 7 February 2024: Reference is made to the stock exchange announcement by Circio Holdi... |
| 05.02.2024 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Mon, Feb 05, 2024 09:48 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 01.02.2024 | The first patient has been dosed in Circio's TG01 triple combination study | The first patient has been dosed in Circio's TG01 triple combination study
Thu, Feb 01, 2024 07:00 CET Report this content
The first enrolled patient was dosed on 31 January in Washington, D.C., USA
In this phase 2 study, the TG01 mutant RA... |
| 22.01.2024 | Circio to present at upcoming conferences | Circio to present at upcoming conferences
Mon, Jan 22, 2024 07:00 CET Report this content
Oslo, Norway, 22 January 2024 – Circio Holding ASA (OSE: CRNA) announces that CEO Erik Digman Wiklund is invited to present at following upcoming conf... |
| 18.01.2024 | Circio receives waiver of EUR 6.2 million in loans from Business Finland | Circio receives waiver of EUR 6.2 million in loans from Business Finland
Thu, Jan 18, 2024 07:54 CET Report this content
Oslo, Norway 18 January 2024 – Circio Holding ASA (OSE: CRNA) today announces that Business Finland has approved Circio... |
| 12.01.2024 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Fri, Jan 12, 2024 10:03 CET Report this content
Oslo, 12 January 2024: Reference is made to the stock exchange announcement by Circio Holdi... |
| 10.01.2024 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Wed, Jan 10, 2024 14:40 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 04.01.2024 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Thu, Jan 04, 2024 10:06 CET Report this content
Oslo, 4 January 2024: Reference is made to the stock exchange announcement by Circio Holdin... |
| 28.12.2023 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Thu, Dec 28, 2023 15:24 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 22.12.2023 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Fri, Dec 22, 2023 16:48 CET Report this content
Oslo, 22 December 2023: Reference is made to the stock exchange announcement by Circio Hold... |
| 19.12.2023 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Tue, Dec 19, 2023 13:47 CET Report this content
Oslo, 19 December 2023: Reference is made to the stock exchange announcement by Circio Hold... |
| 18.12.2023 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Mon, Dec 18, 2023 10:34 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 13.12.2023 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Wed, Dec 13, 2023 12:24 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 12.12.2023 | TG01 IND application filed in China by Circio’s partner IOVaxis Therapeutics | TG01 IND application filed in China by Circio’s partner IOVaxis Therapeutics
Tue, Dec 12, 2023 07:32 CET Report this content The updated TG01 IND application has been filed with the Chinese NMPA, triggering a sixty-day review period Followi... |
| 07.12.2023 | Circio announces completion of planned safety review and opening for full enrollment of TG01 study at Oslo University Hospital | Circio announces completion of planned safety review and opening for full enrollment of TG01 study at Oslo University Hospital
Thu, Dec 07, 2023 07:00 CET Report this content
Seven patients were enrolled in the safety cohort with follow-up ... |
| 30.11.2023 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Thu, Nov 30, 2023 12:07 CET Report this content
Oslo, 30 November 2023: Reference is made to the stock exchange announcement by Circio Hold... |
| 29.11.2023 | Reminder: Circio invites to circular RNA R&D webinar today | Reminder: Circio invites to circular RNA R&D webinar today
Wed, Nov 29, 2023 10:35 CET Report this content
Oslo, Norway, 29 November 2023 – Circio Holding ASA (OSE: CRNA) Circio's management invites to a live R&D webinar featuring a... |
| 24.11.2023 | Circio announces outcome of TG01/gemcitabine combination EU patent proceeding | Circio announces outcome of TG01/gemcitabine combination EU patent proceeding
Fri, Nov 24, 2023 13:00 CET Report this content
The EPO board of appeal moved to revoke the TG01/gemcitabine combination method of use patent in pancreatic cancer... |
| 21.11.2023 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Tue, Nov 21, 2023 16:54 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 16.11.2023 | Circio joins collaboration to test the combination of TG01 vaccination with daratumumab and nivolumab in immunotherapy resistant patients with mutant RAS cancers | Circio joins collaboration to test the combination of TG01 vaccination with daratumumab and nivolumab in immunotherapy resistant patients with mutant RAS cancers
Thu, Nov 16, 2023 07:00 CET Report this content
Circio joins Georgetown Univer... |
| 09.11.2023 | Circio invites to circular RNA R&D webinar Wednesday 29 November 2023 | Circio invites to circular RNA R&D webinar Wednesday 29 November 2023
Thu, Nov 09, 2023 07:00 CET Report this content
Oslo, Norway, 9 November 2023 – Circio Holding ASA (OSE: CRNA) Circio´s management invites to a live R&D webinar f... |
| 26.10.2023 | Circio presents powerful expression data for new generation circVec 2.0 design at the ESGCT 2023 annual meeting | Circio presents powerful expression data for new generation circVec 2.0 design at the ESGCT 2023 annual meeting
Thu, Oct 26, 2023 07:00 CET Report this content
New circVec 2.0 design boosts protein expression by up to 10-fold vs. circVec 1.... |
| 19.10.2023 | Circio: circRNA poster to be presented at the 30th European Society for Gene and Cell Therapy (ESGCT) | Circio: circRNA poster to be presented at the 30th European Society for Gene and Cell Therapy (ESGCT)
Thu, Oct 19, 2023 07:00 CET Report this content
Oslo, Norway, 19 October 2023 – Circio Holding ASA (OSE: CRNA) today announces that an abs... |
| 18.10.2023 | Circio strengthens its focus on next generation circular RNA therapeutics with additional cost reductions | Circio strengthens its focus on next generation circular RNA therapeutics with additional cost reductions
Wed, Oct 18, 2023 07:00 CET Report this content
Closing of Finnish subsidiary
The Board of Directors will be reduced from seven to fou... |
| 10.10.2023 | Circio and Neoregen Biotech enter collaboration for delivery of novel circular RNA therapeutics using NICT technology | Circio and Neoregen Biotech enter collaboration for delivery of novel circular RNA therapeutics using NICT technology
Tue, Oct 10, 2023 07:00 CET Report this content
Circio and Neoregen Biotech today announce the start of a research collabo... |
| 04.10.2023 | Circio Holding ASA - Ex. reverse share split today | Circio Holding ASA - Ex. reverse share split today
Wed, Oct 04, 2023 07:00 CET Report this content Issuer name: Circio Holding ASA Ex. date: 4 October 2023 Type of corporate action: reverse share split Other information: reverse split ratio... |
| 04.10.2023 | Circio invites to a company update on Wednesday 11 October 2023 | Circio invites to a company update on Wednesday 11 October 2023
Wed, Oct 04, 2023 07:10 CET Report this content
Oslo, Norway, 4 October 2023 – Circio Holding ASA (OSE: CRNA): Circio’s management invites to a live webcast on Wednesday 11 Oct... |
| 02.10.2023 | Circio Holding ASA - Key information relating to the change of ISIN | Circio Holding ASA - Key information relating to the change of ISIN
Mon, Oct 02, 2023 15:03 CET Report this content Issuer name: Circio Holding ASA Previous ISIN: NO0010689326 New ISIN: NO0013033795 Date of ISIN change: 4 October 2023 Recor... |
| 02.10.2023 | Circio Holding ASA - New share capital registered | Circio Holding ASA - New share capital registered
Mon, Oct 02, 2023 14:49 CET Report this content
Reference is made to section 4.1 of Oslo Rulebook II, Issuer Rules, and the requirement to have a stock price of minimum NOK 1 per share. At t... |
| 02.10.2023 | Circio Holding ASA - Key information relating to the reverse share split | Circio Holding ASA - Key information relating to the reverse share split
Mon, Oct 02, 2023 15:02 CET Report this content
Please note the following key information for the reverse share split: Reverse split ratio: 30:1, i.e. thirty (30) old ... |
| 28.09.2023 | Circio Holding ASA: Approval and publication of registration document | Circio Holding ASA: Approval and publication of registration document
Thu, Sep 28, 2023 16:08 CET Report this content
Oslo, 28 September 2023: Circio Holding ASA (the "Company") has prepared a registration document to be used as a... |
| 27.09.2023 | Circio Holding ASA: Minutes from the Extraordinary General Meeting | Circio Holding ASA: Minutes from the Extraordinary General Meeting
Wed, Sep 27, 2023 09:41 CET Report this content
The extraordinary general meeting was held on 27 September 2023 at the Company’s offices at Vollsveien 19, 1366 Lysaker.
Plea... |
| 25.09.2023 | Circio: circRNA poster to be presented at the 15th international adenovirus meeting | Circio: circRNA poster to be presented at the 15th international adenovirus meeting
Mon, Sep 25, 2023 07:00 CET Report this content
Oslo, Norway, 25 September 2023 – Circio Holding ASA (OSE: CRNA) today announces that an abstract describing... |
| 21.09.2023 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Thu, Sep 21, 2023 08:55 CET Report this content
Oslo, 21 September 2023: Reference is made to the stock exchange announcement by Circio Hol... |
| 21.09.2023 | Circio Holding ASA - Technical adjustment to item 7 in the Notice of the Extraordinary General Meeting to be held on 27 September 2023 | Circio Holding ASA - Technical adjustment to item 7 in the Notice of the Extraordinary General Meeting to be held on 27 September 2023
Thu, Sep 21, 2023 11:46 CET Report this content
Reference is made to the stock exchange announcement publ... |
| 14.09.2023 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Thu, Sep 14, 2023 16:38 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 07.09.2023 | Circio invites to Q&A webcast regarding Extraordinary General Meeting | Circio invites to Q&A webcast regarding Extraordinary General Meeting
Thu, Sep 07, 2023 09:00 CET Report this content
Oslo, Norway, 7 September 2023: Following the notice of an Extraordinary General Meeting (EGM) to be held 27 September... |
| 06.09.2023 | Circio Holding ASA – Notice of Extraordinary General Meeting | Circio Holding ASA – Notice of Extraordinary General Meeting
Wed, Sep 06, 2023 16:40 CET Report this content
Circio Holding ASA is calling for an EGM on 27 September 2023 to vote on the following items: The amendment to the Investment Agree... |
| 04.09.2023 | ONCOS-102 mesothelioma study published in Journal for ImmunoTherapy of Cancer | ONCOS-102 mesothelioma study published in Journal for ImmunoTherapy of Cancer
Mon, Sep 04, 2023 07:00 CET Report this content ONCOS-102 combined with chemotherapy demonstrated 34.1% overall survival (OS) rate at 30 months in first line pati... |
| 24.08.2023 | Circio Holding ASA: First half 2023 results | Circio Holding ASA: First half 2023 results
Thu, Aug 24, 2023 07:00 CET Report this content
Oslo, Norway, 24 August 2023 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines, to... |
| 24.08.2023 | Circio Holding ASA – Second Tranche of Convertible Bonds | Circio Holding ASA – Second Tranche of Convertible Bonds
Thu, Aug 24, 2023 07:10 CET Report this content
Reference is made to the Investment Agreement entered into between Atlas Special Opportunities, LLC (“Atlas”) and Circio Holding ASA (t... |
| 15.08.2023 | Circio Holding ASA: Invitation to Circio’s first half year 2023 presentation, Thursday 24 August | Circio Holding ASA: Invitation to Circio’s first half year 2023 presentation, Thursday 24 August
Tue, Aug 15, 2023 07:00 CET Report this content
Oslo, Norway, 15 August 2023 – Circio Holding ASA (OSE: CRNA) will announce its first half year... |
| 29.06.2023 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Thu, Jun 29, 2023 09:44 CET Report this content
Oslo, 29 June 2023: Reference is made to the stock exchange announcement by Circio Holding ... |
| 26.06.2023 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Mon, Jun 26, 2023 12:17 CET Report this content
Reference is made to Circio Holding ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Comp... |
| 22.06.2023 | Circio: First patient in multiple myeloma trial dosed with TG01 at Oslo University Hospital | Circio: First patient in multiple myeloma trial dosed with TG01 at Oslo University Hospital
Thu, Jun 22, 2023 07:00 CET Report this content
TG01 monotherapy will be evaluated in 20 patients with RAS-mutated multiple myeloma.
The trial is sp... |
| 15.06.2023 | Circio Holding ASA: June 2022 company update | Circio Holding ASA: June 2022 company update
Thu, Jun 15, 2023 07:00 CET Report this content
Oslo, Norway, 15 June 2023 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing next generation RNA therapeutics, today provides a ... |
| 12.06.2023 | Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members | Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members
Mon, Jun 12, 2023 21:51 CET Report this content
Reference is made to the annual general meeting of Circio Holding ASA (the "Company") on 22 May 202... |
| 31.05.2023 | Circio invites to a company update on Thursday 15 June 2023 | Circio invites to a company update on Thursday 15 June 2023
Wed, May 31, 2023 07:00 CET Report this content
Oslo, Norway, 31 May 2023 – Circio Holding ASA (OSE: CRNA) Circio’s management invite to a live webcast on Thursday 15 June at 10am ... |
| 26.05.2023 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Fri, May 26, 2023 10:02 CET Report this content
Oslo, 26 May 2023: Reference is made to the stock exchange announcement by Circio Holding A... |
| 25.05.2023 | Circio Holding ASA - New name registered | Circio Holding ASA - New name registered
Thu, May 25, 2023 10:29 CET Report this content
Oslo, Norway, 25 May 2023 – Reference is made to the announcement on 19 April 2023 regarding the change of the company’s name from Targovax ASA to Circ... |
| 23.05.2023 | Circio Holding ASA: Requested Conversion of Convertible Bonds | Circio Holding ASA: Requested Conversion of Convertible Bonds
Tue, May 23, 2023 20:52 CET Report this content
Reference is made to Circio Holding ASA's (formerly Targovax ASA) (the "Company") stock exchange announcement on 9 March... |
| 22.05.2023 | Targovax ASA: Minutes from the Annual General Meeting | Targovax ASA: Minutes from the Annual General Meeting
Mon, May 22, 2023 15:08 CET Report this content
The annual general meeting was held on 22 May 2023 at the Company's offices at Vollsveien 19, 1366 Lysaker. Please find minutes of the mee... |
| 16.05.2023 | Circio: Link to recording and presentation from Company update 16[th] May 2023 | Circio: Link to recording and presentation from Company update 16[th] May 2023
Tue, May 16, 2023 15:30 CET Report this content
Oslo, Norway, 16 May 2023 – Circio Holding ASA (formerly Targovax ASA*) (OSE: TRVX)
Circio’s management and Board... |
| 12.05.2023 | Circio invites to a company update on Tuesday 16 May 2023 | Circio invites to a company update on Tuesday 16 May 2023
Fri, May 12, 2023 07:00 CET Report this content
Oslo, Norway, 12 May 2023 – Circio Holding ASA (formerly Targovax ASA*) (OSE: TRVX):
Circio’s management and Board of Directors invite... |
| 03.05.2023 | Circio: circRNA poster to be presented at the ASGCT Annual Meeting | Circio: circRNA poster to be presented at the ASGCT Annual Meeting
Wed, May 03, 2023 07:00 CET Report this content
Oslo, Norway, 3 May 2023 – Circio Holding ASA (formerly Targovax ASA*) (OSE: TRVX) today announces that an abstract describin... |
| 03.05.2023 | Targovax ASA - Correction of the proxy form attached to the notice of the Annual General Meeting | Targovax ASA - Correction of the proxy form attached to the notice of the Annual General Meeting
Wed, May 03, 2023 12:15 CET Report this content
Reference is made to the stock exchange notice published on 28 April 2023 where Targovax ASA (t... |
| 28.04.2023 | Targovax ASA - Notice of Annual General Meeting | Targovax ASA - Notice of Annual General Meeting
Fri, Apr 28, 2023 08:57 CET Report this content
The Annual General Meeting of Targovax ASA (the “Company”) will be held at the Company’s offices at Lysaker, on 22 May 2023 at 14:00 CET.
Notice... |
| 13.04.2023 | Targovax ASA: Registration of share capital increase following conversion of convertible bonds | Targovax ASA: Registration of share capital increase following conversion of convertible bonds
Thu, Apr 13, 2023 12:01 CET Report this content
Oslo, 13 April 2023: Reference is made to the stock exchange announcement by Targovax ASA (OSE:TR... |
| 13.04.2023 | Targovax ASA: Annual Report 2022 | Targovax ASA: Annual Report 2022
Thu, Apr 13, 2023 23:35 CET Report this content
On 13 April 2023, the Board of Directors of Targovax ASA approved the Company’s Annual Report, including the financial statements for 2022, which will be proce... |
| 30.03.2023 | Targovax ASA: Requested Conversion of Convertible Bonds | Targovax ASA: Requested Conversion of Convertible Bonds
Thu, Mar 30, 2023 11:11 CET Report this content
Reference is made to Targovax ASA's (the "Company") stock exchange announcement on 9 March 2023, in which the Company announce... |
| 15.03.2023 | Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting | Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting
Wed, Mar 15, 2023 13:43 CET Report this content
Oslo, Norway, 15 March 2023 - Targovax ASA (OSE: TRVX) today announces that an abstract describing its circular RNA plat... |
| 14.03.2023 | Targovax: First patient dosed with TG01 in the USA | Oslo, Norway, 14 March 2023 – Targovax ASA (OSE: TRVX), today announces that the first patient has been dosed with cancer vaccine TG01 in the combination study with PD-1 checkpoint inhibitor (CPI) balstilimab in mutant RAS pancreatic cancer... |
| 14.03.2023 | Targovax: First patient dosed with TG01 in the USA | Targovax: First patient dosed with TG01 in the USA
Tue, Mar 14, 2023 08:27 CET Report this content
The first patient has been dosed with TG01 at The University of Kansas Cancer Center
In this study, mutant RAS vaccine TG01 is being tested i... |
| 09.03.2023 | Targovax ASA – First Tranche of Convertible Bonds | Targovax ASA – First Tranche of Convertible Bonds
Thu, Mar 09, 2023 20:46 CET Report this content
Reference is made to the Investment Agreement entered into between Atlas Special Opportunities, LLC ("Atlas") and Targovax ASA (the ... |
| 09.03.2023 | Targovax ASA: Minutes from the Extraordinary General Meeting | Targovax ASA: Minutes from the Extraordinary General Meeting
Thu, Mar 09, 2023 10:55 CET Report this content
The annual general meeting was held on 9 March 2023 at the Company’s offices at Vollsveien 19, 1366 Lysaker.
Please find minutes of... |
| 08.03.2023 | Targovax to prioritize resources on unlocking the potential of its circRNA platform | Oslo, Norway, 7 March 2023 Targovax ASA (OSE: TRVX) today announces that it will focus existing financial resources on developing its circular RNA (circRNA) platform to capitalize on its significant early-mover advantage and globally compet... |
| 07.03.2023 | Targovax to prioritize resources on unlocking the potential of its circRNA platform | Targovax to prioritize resources on unlocking the potential of its circRNA platform
Tue, Mar 07, 2023 17:49 CET Report this content
Targovax has an early-mover advantage in circRNA, a novel area of RNA therapeutics attracting substantial in... |
| 06.03.2023 | Targovax ASA – Additional information prior to the Extraordinary General Meeting | Targovax ASA – Additional information prior to the Extraordinary General Meeting
Mon, Mar 06, 2023 17:44 CET Report this content
Oslo, Norway, 6 March 2023: Reference is made to Targovax ASA's ("Targovax" or the "Company"... |
| 06.03.2023 | Targovax ASA: Registration of share capital increase following settlement of restricted stock units | Targovax ASA: Registration of share capital increase following settlement of restricted stock units
Mon, Mar 06, 2023 15:33 CET Report this content
Oslo, 6 March 2023: Reference is made to the stock exchange announcement by Targovax ASA (OS... |
| 02.03.2023 | Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs | Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs
Thu, Mar 02, 2023 13:24 CET Report this content
Oslo, 2 March 2023: Reference is made to Targovax ASA's ("Targovax" or the "Company") s... |
| 02.03.2023 | Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital | Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital
Thu, Mar 02, 2023 13:15 CET Report this content
Oslo, 2 March 2023: The board of directors of Targovax ASA (OSE:TRVX) ("Targovax" or t... |
| 01.03.2023 | Targovax ASA – Additional information prior to the Extraordinary General Meeting | Targovax ASA – Additional information prior to the Extraordinary General Meeting
Wed, Mar 01, 2023 07:00 CET Report this content
Oslo, Norway, 1 March 2023: Reference is made to Targovax ASA's ("Targovax" or the "Company"... |
| 23.02.2023 | Targovax invites to Q&A webcast regarding convertible bond financing | Targovax invites to Q&A webcast regarding convertible bond financing
Thu, Feb 23, 2023 11:49 CET Report this content
Oslo, Norway, 23 February 2023: Following the announcement on 16 February 2023 of a proposed convertible bond financing... |
| 16.02.2023 | Targovax ASA: Fourth quarter 2022 results | Oslo, Norway, 16 February 2023 – Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its fourth quarter 2022 results.
Members of Targovax’s exe... |
| 16.02.2023 | Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform | Oslo, Norway, 16 February 2023 – Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target solid tumors, today announces that it has agreed the terms and conditions for a convertible bond faci... |
| 16.02.2023 | Targovax ASA: Fourth quarter 2022 results | Targovax ASA: Fourth quarter 2022 results
Thu, Feb 16, 2023 07:00 CET Report this content
Oslo, Norway, 16 February 2023 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat... |
| 16.02.2023 | Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform | Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform
Thu, Feb 16, 2023 06:55 CET Report this content The financing will support initiation of the ON... |
| 16.02.2023 | Targovax ASA – Notice of Extraordinary General Meeting | Targovax ASA – Notice of Extraordinary General Meeting
Thu, Feb 16, 2023 17:49 CET Report this content
Reference is made to Targovax ASA's ("Targovax" or the "Company") stock exchange announcement on 16 February 2023 whe... |
| 10.02.2023 | Targovax ASA: Invitation to Targovax’s fourth quarter 2022 presentation, Thursday 16 February | Oslo, Norway, 8 February 2023 – Targovax ASA (OSE: TRVX) will announce its fourth quarter 2022 results on Thursday 16 February 2023. Targovax’s management will present the results at a live streamed webcast at 10:00 am CET to investors, ana... |
